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Low molecularweight GTP-binding proteins are molecular 
switches that control a diverse array of biological pro- 
cesses (Bourne et al., 1991). When bound to GTP, these 
proteins transduce signals to effector proteins. When 
bound to GDP, these proteins are in an inactive state. 
The cycling between the active, GTP-bound state and the 
inactive, GDP-bound state is controlled by positive and 
negative modulators that directly contact the GTP-binding 
protein. Positive modulators, guanine nucleotide dissocia- 
tion stimulators (GDSs), catalyze the dissociation of GDP. 
Subsequently, GTP binds, and the protein is active. Nega- 
tive modulators, GTPase-activating proteins (GAPS), stim- 
ulate the intrinsic GTP hydrolytic activity of the GTP- 
binding proteins and, hence, the formation of the inactive, 
GDP-bound state. 
Approximately 50 low molecular weight GTPases have 
been described (Chardin, 1991). The family members can 
be subdivided, on the basis of sequence homology, into 
five classes: Ras, Rab, Arf, Ran, and Rho. Ras family 
members (H-Ras, K-Ras, N-Ras, R-Ras, TC21, RaplAl 
Rap1 B, and RapPAIRapPB) play salient roles in cell growth 
and development. The members of the Rab/Arf subfamil- 
ies monitor and direct the movements of vesicles within 
the cell. Ran is required for nuclear protein import. And, 
finally, the Rho family members (Cdc42/G25K, Racl, 
Rac2, RhoA, RhoB, and RhoC) play dynamic roles in the 
regulation of the actin cytoskeleton. 
Regulated changes in the actin cytoskeleton are re- 
quired for cytokinesis, for cell motility, for vesicle traffick- 
ing, for pinocytosis, and, in the yeast Saccharomyces cer- 
evisiae, for bud site selection and for polarized cell growth. 
Each of the small GTPases of the Rho subfamily partici- 
pates in distinct patterns of actin reorganization. Rat is 
required for membrane ruffling, whereas Rho is required 
for the formation of stress fibers (Ridley and Hall, 1992; 
Ridley et al., 1992). Cdc42 was first identified in the yeast 
S. cerevisiae, where it is required for polarized cell growth 
(Adamset al., 1990); subsequently, a homolog of this yeast 
protein, Cdc42Hs (G25K), was identified from mammalian 
cells, where it regulates the formation of actin-containing 
microspikes, called filopodia (Kozma et al., 1995; Nobes 
and Hall, 1995). 
The observation that chronic activation of Cdc42, Rat, 
and Rho by deregulated exchange factors induces malig- 
nant transformation as well as morphological changes 
(Khosravifar et al., 1994; Michiels et al., 1995) has sug- 
gested that these GTPases may regulate nuclear as well 
as cytoplasmic effects. Three recent papers in Cell (Coso 
et al., 1995; Minden et al., 1995; Hill et al., 1995) describe 
a link from these GTP-binding proteins to the nucleus and, 
for Cdc42 and Rat, to a mitogen-activating protein kinase 
(MAPK) cascade. 
Coso et al. (1995) and Minden et al. (1995) made exten- 
sive use of transient transfection assays with an epitope- 
tagged cJun N-terminal kinase (JNK)/stress-activated pro- 
tein kinase (SAPK) cDNA clone as reporter. Protein kinase 
assays of the recovered tagged JNK were used to monitor 
activity of the MAPK pathway that leads to the JNKs (in 
order, MAP or extracellular-regulated kinase [ERK] kinase 
1 [MEKKl], SAP or ERK kinase [SEKIIMAPK kinase 4 
[MKK4], and JNK; Figure 1). By cotransfecting various 
mutants of Cdc42, Racl, and RhoA that lock the small 
GTPase into a constitutively active or inactive state, Coso 
et al. and Minden et al. were able to show that JNK activa- 
tion is dependent on Cdc42 and Racl , but not RhoA. In 
addition, transfection of a RhoGAP, which inactivates all 
Rho family members, reduces activation of JNK by cyto- 
kines, and transfection of Dbl or Ost, GDSs for Cdc42 
and also RhoA, efficiently activates JNK. The Dbl-induced 
activation of JNK was abolished upon cotransfection of 
JNK with an N-terminal region of the serinelthreonine ki- 
nase PAK85 (Manser et al., 1994; Martin et al., 1995) 
which includes a Cdc42IRacbinding domain and may be 
expected to block signaling from Dbl through Cdc42 by 
titrating the GTPase. This result indicates that the Dbl acti- 
vation of JNK is mediated through its activation of Cdc42, 
not RhoA. Minden et al. also detected activation of Jun 
(a JNK substrate) in cells expressing activated Rat and 
showed that Rat activation of JNK is blocked by kinase- 
defective mutants of either SEWMKK4 or MEKKl, which 
are expected to sequester their respective activators. 
These results suggest that Cdc42 and Racl can activate 
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Figure 1. Rho Family Members Cdc42 and Rat Activate a MAPK Cas- 
cade 
The classical MAPK cascade is a linked series of kinases: MAPK ki- 
nase kinase (MAPKKK), MAPK kinase (MAPKK), and MAPK. For 
ERKs, this pathway contains, in order, the serine/threonine kinase 
Raf; MEK, also called MAPK kinase (MKK); and ERK. The small GTP- 
binding protein Ras activates this cascade. Binding of Ras to Raf 
localizes Raf to the plasma membrane, where a second (undefined) 
event takes place to activate the Raf kinase activity. Two members 
of the Rho family, Cdc42 and Rat, activate MEKKl, SEWMKK4, and 
JNWSAPK. Whereas Ras directly contacts the MAPKKK, Raf, Cdc42, 
and Rat contact the MAPKKKK, PAK65. PAK65 activates MEKKl, 
but this connection may not be direct. (The broken lines indicate that 
the links may not be direct.) Cross-talk between Ras family members 
Ras and Rat and between Ras and MEKKI has also been reported. 
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MEKKl (a JNK kinase kinase) and the subsequent mem- 
bers of the kinase cascade in much the same way that Ras 
activates Raf (a MAPK kinase kinase) and its downstream 
effects (Figure 1). Just as Ras directly contacts Raf, the 
link from Cdc42 and Racl to MEKKl may be direct, with 
Cdc42 and Racl binding to MEKKl But the present as- 
sumption is that the interaction is mediated by PAK65. 
PAK65 was identified as a Cdc42- and Rat-binding pro- 
tein (Manser et al., 1994; Martin et al., 1995). Binding of 
PAK65 to Cdc42 and Rat is direct, requires active (GTP- 
bound) Cdc42 or Rat, and stimulates the catalytic activity 
of the kinase (autophosphorylation and phosphorylation 
of an exogenous substrate, myelin basic protein). Intrigu- 
ingly, the sequence of PAK65 resembles that of budding 
yeast StePO, an upstream activator of MAPK cascades 
that are required for pheromone and invasive growth re- 
sponses (Herskowitz, 1995). The homology of PAK65 to 
Ste20 and StePO’s link to a MAPK cascade suggests the 
possibility that PAK65 will couple Cdc42/Rac to a MAPK 
cascade. But, as with the link of Ste20 to its downstream 
effector Stell, it remains to be determined whether 
PAK65 directly activates MEKKl. 
Whereas the cytoskeletal effects of Cdc42 and Racl 
are distinct, the evidence suggests that both proteins acti- 
vate the same kinase cascade. This conclusion is based 
in part on the overexpression of dominant inhibitory and 
activated mutants. Of particular concern, the effects of 
activated mutants and their normal counterparts may dif- 
fer. The mutant proteins may have higher levels of GTP 
loading than normal counterparts, are active permanently 
rather than temporarily, and may be abnormally localized, 
permitting them to interact with effecters they do not nor- 
mally contact. Therefore, demonstration of physiological 
regulation of the GTPases is crucial, but may be quite 
difficult experimentally. 
And what of the third family member, RhoA? RhoA does 
not regulate the JNK pathway. Rather, as demonstrated 
by Hill et al. (1995) RhoA is required for signaling to the 
serum response factor (SRF) by serum, lysophosphatidic 
acid (LPA), and aluminum fluoride (AIF,-), agents that 
act through a pertussis toxin-sensitive heterotrimeric G 
protein. 
At the c-Fos serum response element (SRE), activated 
ternary complex factor (TCF) and activated SRF cooperate 
for maximal gene expression (Treisman, 1994). Growth 
factors signal to TCF through the Ras-Raf-Erk pathway. 
Mutants of the c-fos promoter that cannot bind TCF none- 
theless are still responsive to serum, LPA, and AIF4-. This 
response is independent of the Ras-Raf-Erk pathway but 
dependent on SRF. Hill et al. have identified Rho family 
members as regulators of this TCF-independent, SRF- 
dependent signaling pathway. 
In a series of elegant experiments, Hill et al. demon- 
strated that activated versions of three Rho family mem- 
bers, Cdc42Hs Racl, and RhoA, induce transcription 
from a TCF-independent c-fos reporter gene and that the 
TCF- and SRF-dependent signaling pathways are likely 
to converge at the SRE and to act synergistically at the 
SRE. Moreover, use of bacterial C3 exoenzyme, which 
specifically inhibits RhoA, indicated that the activation of 
SRF by Cdc42 and Racl occurs independently of RhoA, 
whereas activation by extracellular agents, such as LPA, 
depends on RhoA. The RhoA dependence of SRF activa- 
tion is unlikely to be an artifact of the cytoskeletal disrup- 
tion caused by RhoA inhibition, since SRF is activated, 
not inhibited, in cytochalasin-treated cells. This suggests 
that at least two signaling pathways mediated by Rho fam- 
ily members converge on SRF. 
Clearly, the involvementof RhoAdistinguishesSRFacti- 
vation from that of JNK, and external stimuli that activate 
JNK do not necessarily activate SRF. This study suggests 
the existence of novel signaling pathways to SRF that are 
dependent on Rho family members. How are the effects 
of Rho family members transmitted to SRF? It is tempting 
to speculate that, analogous to the Cdc42/Racl link to 
JNK, RhoA will also couple to a MAPK cascade, perhaps 
by activation of a Rho-specific StePO or MEKK homolog 
(Figure 2). 
With the identification of Rho family members as activa- 
tors of MAPK cascades, it seems likely that many or all 
MAPK pathways might be controlled by small GTPases, 
possibly in cooperation with “second signals” provided by 
other kinases or small molecules. Second signals (coacti- 
vators) are likely to play an important role in the Ras- 
Raf pathway. RasGTP acts to localize Raf to the plasma 
membrane, where a second, ill-defined event takes place 
to activate the Raf catalytic activity (Leevers et al., 1994). 
As with Ras and Raf, GTP-bound Cdc42IRacl may pro- 
vide a permissive environment for PAK65 activation, for 
example, by localizing PAK65 to an appropriate cellular 
compartment, where a second, regulated signal may be 
delivered by a protein kinase or, perhaps, a phospholipid 
metabolite. A requirement for a second signal might ex- 
plain apparent roles for Ras in JNK activation and RhoA- 
dependent SRF activation, although Ras could alterna- 
tively regulate SRF by producing a substrate for a 
RhoA-activated enzyme (Hill et al., 1995). Additional stud- 
ies are sure to be forthcoming to determine what role, if 
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Figure 2. Rho Family Members Cdc42Hs, Racl, and RhoA Regulate 
the Activity of the SRF at the SRE 
At least two independent signaling pathways converge on the SRF: 
RhoA and Cdc42lRacl. The intermediate steps between the Rho fam- 
ily members and SRF are enigmatic. But since Rho family members 
mediate the stress response through activation of a MAPK cascade, 
it is tempting to speculate that activation of the SRF by Rho family 
members will also involve a MAPK cascade, perhaps initatiated by a 
novel p21-activated kinase (PAK). 
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any, second activating signals play in the kinase cascades 
activated by Rho family members. 
The activities of Ras, Cdc42, Racl, and RhoA seem 
to be interdependent. Growth factors and constitutively 
active Ras stimulate stress fiber formation by activating 
Rat and Rho, and membrane ruffling depends on Rat 
(Ridley and Hall, 1992; Ridley et al., 1992). Somewhat 
paradoxically, experiments with dominant negative mu- 
tants, toxin, and GAPS indicate that Racl and RhoA are 
also required for morphological transformation by Ras (Qiu 
et al., 1995; Prendergrast et al., 1995), a process that 
involves cell rounding and loss of stress fibers. Cdc42 also 
appears to activate Rat and Rho (Nobes and Hall, 1995). 
Therefore, it is possible that the Rat- and Rho-dependent 
nuclear events and the Cdc42/Rac-dependent JNK cas- 
cade are also regulated by Ras. 
The possible links between these small GTPases are rap- 
idly being discovered. Phospholipid metabolites or direct 
protein interactions may be important. In mammalian cells, 
Racl may be activated by specific phdsphoinositides that 
are produced by phosphatidylinositol 3-kinase (Hawkins 
et al., 1995). That enzyme may be activated directly by 
Ras (Rodriguez-Viciana et al., 1994) or may be activated 
indirectly in Ras-transformed cells by autocrine stimula- 
tion. Rho, in turn, is activated by arachidonic acid metab- 
olites produced when Racl is activated (Peppelenbosch 
et al., 1995). And the discovery of Cdc42- and Racl- 
stimulated protein kinases raises the possibility that pro- 
tein phosphorylation will link one small GTPase to another 
(Figure 3). 
The discovery of transcriptional regulation by Rho family 
GTPases helps explain the common isolation of RhoGDS 
genes as oncogenes, able to cause complete morphologic 
and mitogenic transformation (e.g., Horii et al., 1994). 
What are the implications of kinase regulation for the cyto- 
plasmic effects of RhoGTPases? Are the Cdc42- and Rac- 
induced reorganizations of the actin cytoskeleton medi- 
ated (or influenced) bytheir downstream kinase cascades, 
1 Racl , RhoA 
Figure 3. Lines of Communication 
As kinases are linked to one another in cascades, so too are small 
GTP-binding proteins. But the molecular links between GTP-binding 
protein cascades remain largely unexplored. Do kinase cascades, 
other cytoplasmic effectors, phospholipid metabolites, or all of these 
link one GTP-binding protein to the next? Other largely unexplored 
questions include the following. Do the kinase cascades branch? Are 
there multiple substrates for the MAPKKKK, MAPKKK, or MAPKK? 
What are the effecters for the Rat- and Rho-induced cytoskeletal 
changes: kinase cascades or other effecters? Can cytoskeletal alter- 
ations by small GTP-binding proteins (or between cascades of G pro- 
teins) take place entirely in the cytoplasm, without involving the nu- 
cleus? The broken lines indicate that the links may not be direct. 
or are there other cytoplasmic effecters? Many of the cy- 
toskeletal changes required for cell shape alterations and 
movement, such as the production and reabsorption of 
microspikes(Cdc42dependent), lamellipodia(Racdepen- 
dent), and adhesion contacts and stress fibers (RhoA de- 
pendent), occur on a time scale of minutes, so these cy 
toskeletal alterations may be coordinated between small 
molecular mass GTP-binding proteins at the cell surface, 
without involving the nucleus. Defining the mechanisms 
for cross-talk between small molecular mass GTP-binding 
proteins, as well as understanding how one particular 
GTP-binding protein regulates events in different cellular 
compartments (Cell surface, nucleus) coordinately or mde- 
pendently, depending on stimulus, should prove to be an 
exciting area for future experiments. 
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